The effect of changing serum 25-hydroxyvitamin D concentrations on metabolic syndrome: A longitudinal analysis of participants of a preventive health program

Nutrients

Volumn 7, Issue 9, 2015, Pages 7271-7284

  Pham, Truong Minh ^a   Ekwaru, John Paul ^a   Setayeshgar, Solmaz ^a   Veugelers, Paul J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Longitudinal study; Metabolic syndrome; Serum 25(OH)D; Vitamin D; Vitamin D supplementation

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CANADIAN; CARDIOVASCULAR DISEASE; CHEMILUMINESCENCE IMMUNOASSAY; COUNSELING; DIET; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; QUESTIONNAIRE; RISK FACTOR; SLEEP; STRESS MANAGEMENT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; AGED; ALBERTA; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; HEALTH STATUS; LONGITUDINAL STUDY; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; PROCEDURES; PROGRAM EVALUATION; SEASON; TIME FACTOR; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADULT; AGED; ALBERTA; BIOMARKERS; DIETARY SUPPLEMENTS; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; PROGRAM EVALUATION; SEASONS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84940836541     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7095338     Document Type: Article

References (34)

1. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112, 2735-2752. [CrossRef] [PubMed]
2. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr.; et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640-1645. [PubMed]
3. Wilson, P.W.; D'Agostino, R.B.; Parise, H.; Sullivan, L.; Meigs, J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112, 3066-3072. [CrossRef] [PubMed]
4. Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113-1132. [CrossRef] [PubMed]
5. Grundy, S.M. Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 629-636. [CrossRef] [PubMed]
6. Riediger, N.D.; Clara, I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ 2011, 183, E1127-E1134. [CrossRef] [PubMed]
7. Sheets, D.J.; Gallagher, E.M. Aging in Canada: State of the art and science. Gerontologist 2013, 53, 1-8. [CrossRef] [PubMed]
8. Holick, M.F. Vitamin D status: Measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73-78. [CrossRef] [PubMed]
9. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281. [CrossRef] [PubMed]
10. Bischoff-Ferrari, H.A. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv. Exp. Med. Biol. 2008, 624, 55-71. [PubMed]
11. Giovannucci, E.; Liu, Y.; Rimm, E.B.; Hollis, B.W.; Fuchs, C.S.; Stampfer, M.J.; Willett, W.C. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl. Cancer Inst. 2006, 98, 451-459. [CrossRef] [PubMed]
12. Wang, T.J.; Pencina, M.J.; Booth, S.L.; Jacques, P.F.; Ingelsson, E.; Lanier, K.; Benjamin, E.J.; D'Agostino, R.B.; Wolf, M.; Vasan, R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117, 503-511. [CrossRef] [PubMed]
13. Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B.; et al. Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [CrossRef] [PubMed]
14. Vitezova, A.; Zillikens, M.C.; van Herpt, T.T.; Sijbrands, E.J.; Hofman, A.; Uitterlinden, A.G.; Franco, O.H.; Kiefte-de Jong, J.C. Vitamin D status and metabolic syndrome in the elderly: The Rotterdam Study. Eur. J. Endocrinol. 2015, 172, 327-335. [CrossRef] [PubMed]
15. Ford, E.S.; Ajani, U.A.; McGuire, L.C.; Liu, S. Concentrations of serum vitamin D and the metabolic syndrome among, U.S. adults. Diabetes Care 2005, 28, 1228-1230. [CrossRef] [PubMed]
16. Brenner, D.R.; Arora, P.; Garcia-Bailo, B.; Wolever, T.M.; Morrison, H.; El-Sohemy, A.; Karmali, M.; Badawi, A. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin. Investig. Med. 2011, 34, 377-384.
17. Kayaniyil, S.; Vieth, R.; Harris, S.B.; Retnakaran, R.; Knight, J.A.; Gerstein, H.C.; Perkins, B.A.; Zinman, B.; Hanley, A.J. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J. Clin. Endocrinol. Metab. 2011, 96, 168-175. [CrossRef] [PubMed]
18. Kim, M.K.; Il Kang, M.; Won Oh, K.; Kwon, H.S.; Lee, J.H.; Lee, W.C.; Yoon, K.H.; Son, H.Y. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin. Endocrinol. (Oxf.) 2010, 73, 330-338. [CrossRef] [PubMed]
19. Hypponen, E.; Boucher, B.J.; Berry, D.J.; Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: A cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008, 57, 298-305. [CrossRef] [PubMed]
20. Ju, S.Y.; Jeong, H.S.; Kim do, H. Blood vitamin D status and metabolic syndrome in the general adult population: A dose-response meta-analysis. J. Clin. Endocrinol. Metab. 2014, 99, 1053-1063. [CrossRef] [PubMed]
21. Gagnon, C.; Lu, Z.X.; Magliano, D.J.; Dunstan, D.W.; Shaw, J.E.; Zimmet, P.Z.; Sikaris, K.; Ebeling, P.R.; Daly, R.M. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J. Clin. Endocrinol. Metab. 2012, 97, 1953-1961. [CrossRef] [PubMed]
22. Kayaniyil, S.; Harris, S.B.; Retnakaran, R.; Vieth, R.; Knight, J.A.; Gerstein, H.C.; Perkins, B.A.; Zinman, B.; Hanley, A.J. Prospective association of 25(OH)D with metabolic syndrome. Clin. Endocrinol. (Oxf.) 2014, 80, 502-507. [CrossRef] [PubMed]
23. Skaaby, T.; Husemoen, L.L.; Pisinger, C.; Jorgensen, T.; Thuesen, B.H.; Fenger, M.; Linneberg, A. Vitamin D status and changes in cardiovascular risk factors: A prospective study of a general population. Cardiology 2012, 123, 62-70. [CrossRef] [PubMed]
24. Al-Daghri, N.M.; Alkharfy, K.M.; Al-Saleh, Y.; Al-Attas, O.S.; Alokail, M.S.; Al-Othman, A.; Moharram, O.; El-Kholie, E.; Sabico, S.; Kumar, S.; et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: A 12-month prospective study. Metabolism 2012, 61, 661-666. [CrossRef] [PubMed]
25. Ekwaru, J.P.; Zwicker, J.D.; Holick, M.F.; Giovannucci, E.; Veugelers, P.J. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin d in healthy volunteers. PLoS ONE 2014, 9, e111265. [CrossRef] [PubMed]
26. Heaney, R.P.; French, C.B.; Nguyen, S.; Ferreira, M.; Baggerly, L.L.; Brunel, L.; Veugelers, P. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv. Nutr. 2013, 4, 303-310. [CrossRef] [PubMed]
27. Heaney, R.P. Toward a physiological referent for the vitamin D requirement. J. Endocrinol. Investig. 2014, 37, 1127-1130. [CrossRef] [PubMed]
28. Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419. [CrossRef] [PubMed]
29. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D; The National Academies Press: Washington, DC, USA, 2011.
30. Langlois, K.; Greene-Finestone, L.; Little, J.; Hidiroglou, N.; Whiting, S. Vitamin D status of Canadians as measured in the 2007 to 2009 Canadian Health Measures Survey. Health Rep. 2010, 21, 47-55. [PubMed]
31. Janz, T.; Pearson, C. Vitamin D Blood Levels of Canadians. In Health at a Glance; Statistics Canada: Ottawa, ON, Canada, 2013; (Catalogue No 82-624-X). Available online: http://www.statcan.gc.ca/pub/82-624-x/2013001/article/11727-eng.pdf (accessed on 4 August 2015).
32. Rucker, D.; Allan, J.A.; Fick, G.H.; Hanley, D.A. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002, 166, 1517-1524. [PubMed]
33. Lipscombe, L.L.; Hux, J.E. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet 2007, 369, 750-756. [CrossRef]
34. Lau, R.S.; Ohinmaa, A.; Johnson, J. Predicting the Future Burden of Diabetes in Alberta from 2008 to 2035. Can. J. Diabetes 2011, 35, 274-281. [CrossRef]